Background: Wnt protein secretion and paracrine signaling typically require the enzyme PORCN,
Introduction
Wnt signaling is an ancestrally conserved pathway that plays fundamental roles in numerous facets of embryonic development and adult tissue homeostasis. Dysregulation of Wnt signaling is a causative factor for a range of human pathologies, including several forms of cancer (reviewed in [1] ). As a result, inhibition of Wnt signaling has become an attractive therapeutic target with ongoing clinical trials, with some strategies focused on inhibiting the action of Wnt proteins [1] [2] [3] . Wnt proteins comprise a family of secreted glycoproteins that act as inter-cellular ligands, which stimulate a myriad of signal transduction cascades regulating cellular proliferation, stem cell renewal, cell motility, angiogenesis, and apoptosis [1, [4] [5] [6] . Wnt proteins are post-translationally modified by the O-acyltransferase Porcupine (PORCN), which palmitoylates Wnt proteins at conserved serine residues [2, 7, 8] . This lipidation forms a binding motif for interaction with Wntless (WLS), which chaperones Wnt proteins to the plasma membrane for secretion [8] [9] [10] . Once secreted, Wnt proteins signal in a paracrine manner, binding nearby receptor complexes.
Wnts typically bind a Frizzled (FZD) receptor in conjunction with the LRP5 or LRP6 co-receptor, resulting in second messenger activation (Dishevelled proteins; DVL1/2/3 in humans) and initiation of either canonical (β-catenin-dependent) or non-canonical (β-catenin-independent) signaling [1, 4] . The essential initiating step in Wnt processing is palmitoylation by PORCN, which has prompted development of PORCN inhibitors, including the IWP class of compounds [10] , WNT974 (a.k.a.
LGK974) [3] , and others [2, 11] . These compounds have been shown to block Wnt secretion, inhibit downstream Wnt signaling, and suppress Wnt-driven tumor growth in animal models [3, 12, 13] ; WNT974 is also currently in Phase I/II clinical trials for cancer treatment (NCT01351103, NCT02278133). Based on these observations, PORCN inhibitors are an attractive strategy to target Wntdriven pathologies.
The Wnt protein WNT4 is critical in organogenesis of endocrine organs, regulation of bone mass, and in several steroid hormone-related phenotypes in humans [14] [15] [16] [17] [18] [19] [20] [21] . WNT4 dysregulation, including loss-offunction mutations, results in developmental female to male sex reversal and related phenotypes [22] [23] [24] [25] .
WNT4 polymorphisms have been associated with endocrine dysfunction, reduced bone density with premature skeletal aging, and related phenotypes [26] [27] [28] [29] [30] [31] . WNT4 is also critical in mammary gland development, as Wnt4 knockout in mice prevents progesterone-driven ductal elongation and branching of the mammary gland during pregnancy [32, 33] . In this context, activated progesterone receptor drives expression of Wnt4 in mammary gland luminal cells resulting in paracrine signaling that supports maintenance of the mammary stem cell niche [6, [34] [35] [36] .
We recently reported that regulation of WNT4 expression is co-opted by the estrogen receptor in a subtype of breast cancer, invasive lobular carcinoma (ILC) [37, 38] . Estrogen-driven WNT4 is required in ILC cells for estrogen-induced growth, as well as anti-estrogen resistance [38] . Despite the observed critical roles of WNT4 in both normal and malignant tissues, WNT4 signaling is crudely understood. Both human and murine WNT4 are reported to activate either canonical or non-canonical Wnt signaling in a context and tissue-specific manner (described in above references). Additionally, conflicting reports indicate Wnt4 can or cannot activate canonical Wnt signaling in murine mammary gland [34, 39] . Further, ILC cells lack the capacity to engage canonical Wnt signaling, as β-catenin protein is lost due to the characteristic loss of E-cadherin in ILC [38, 40] . It is also unclear which FZD receptor complexes are utilized by WNT4, although WNT4 is often required for distinct, non-redundant functions, leading to the description of WNT4 as a "problem child" among Wnt proteins (reviewed in [33] ). Based on these observations, inhibition of WNT4 signaling upstream of Wnt effector pathways, such as with PORCN inhibitors, is an attractive approach to block WNT4 signaling in a "pathway indifferent" manner.
Since WNT4 is critical for the proliferation and survival of ILC cells, we expected a similar requirement for PORCN. However, treatment of cells with PORCN inhibitors did not suppress growth or survival.
These unexpected results initiated further studies into the mechanisms of WNT4 secretion and signaling.
In this report, we show WNT4 secretion is mediated by atypical mechanisms. However, our observations call into question whether secretion is required for Wnt signaling and suggest a novel mechanism by which Wnt proteins, including WNT4, can initiate non-canonical Wnt signaling.
Methods and Materials
Cell culture HT1080 and PORCN-knockout HT1080 (HT1080-PKO; clone delta-19) were a generous gift from Dr.
David Virshup [41] , and were maintained in DMEM/F12 (Corning, 10092CV) + 10% FBS (Nucleus Biologics, #FBS1824). HT1080 and HT1080-PKO Wnt over-expression lines were generated by lentiviral transduction of Wnt expression plasmids (see below) and selection of antibiotic-resistant pools, and were maintained in 2.5 μg/mL blasticidin. MDA MB 134VI (MM134; ATCC) and SUM44PE (Asterand) were maintained as described [37] . MM134 overexpression lines were generated by lentiviral transduction of Wnt expression plasmids and selection of antibiotic-resistant pools, and were maintained in 2.5 μg/mL blasticidin. MC3T3-E1 (ATCC) were maintained in MEM Alpha without ascorbic acid (Gibco #A10490-01) + 10% FBS. All lines were incubated at 37°C in 5% CO 2 . Cell lines are authenticated annually by the University of Arizona Genetics Core cell line authentication service, and confirmed to be mycoplasma negative every four months. Authenticated cells were in continuous culture <6 months.
Reagents and plasmids
LGK974 was obtained from Cayman Chemical (#14072) and was dissolved in DMSO. WntC59 was obtained from Tocris Biosciences (#5148) and was dissolved in DMSO. Fulvestrant was obtained from Tocris Biosciences (#1047) and was dissolved in EtOH. Recombinant human WNT3A (#5036-WN-010) and WNT4 (#6076-WN-005) were obtained from R&D Systems, and reconstituted per the manufacturer's instructions.
Wnt plasmids used in this publication were a gift from Drs. Marian Waterman, David Virshup and Xi He (Addgene kit #1000000022) [8] . Lentiviral vectors for WNT3A and WNT4 were generated by Gateway Recombination of pENTR-STOP Wnt open reading frames to pLX304, a kind gift from Dr. Bob Sclafani.
Transient transfection assays
HT1080 cells were transfected with Active WNT3A-V5 (G-8) and Active WNT4-V5 (G-10) from Addgene kit #1000000022. The transfection used Lipofectamine LTX Reagent with PLUS Reagent (ThermoFisher, Cat# 15338100) using the manufacturer's instructions.
Protein extraction from conditioned medium
HT1080 or MM134 cells were plated in full medium (as above, 10% FBS). 24hrs later, medium was changed to reduced FBS medium: DMEM/F12 + 2% FBS for HT1080 cells and DMEM/L15 + 5% FBS for MM134 cells. Decreased FBS was required to reduce competition of serum proteins with secreted Wnt proteins during extraction. Conditioned medium was harvested 4-5 days later for HT1080 cells and 6-7 days later for MM134 cells, typically once medium acidification was apparent by phenol red color change. Medium was centrifuged at 300xg for 4min to pellet any cells or debris. The supernatant was then syringe-filtered using a 0.2μm filter. The protein concentration of the conditioned medium was measured using a Pierce BCA Protein Assay Kit (#23225), and medium volumes normalized to total protein were adjusted with sterile-filtered PBS. Strataclean resin (Agilent, #400714) was added to the conditioned media at a ratio of 10μL of resin to 100μg of protein, and vortexed to re-suspend the resin. The medium+resin mixture was incubated, rotating at 4C for 30min, then centrifuged at 425xg for 1min at 4C.
The supernatant was then aspirated and the resin was washed using sterile-filtered PBS. The resin was centrifuged again at 425xg for 1min at 4C, and the supernatant was aspirated. An equal volume of 2X Laemmli sample buffer (BioRad, #1610737) was added to the resin to release bound protein, and the slurry was heated at 95C for 5min. Slurry equivalent to 100ug of conditioned medium protein was run on SDS-PAGE gels to detect secreted WNT3A or WNT4 via immunoblotting (below).
Alkaline phosphatase assay
MC3T3-E1 cells were seeded into a 96-well plate at 10,000 cells/well. 24hrs later the cells were treated with either conditioned media (CM) or recombinant WNTs (rWNTs). 72hrs later, alkaline phosphatase activity was assessed, using para-Nitrophenyl phosphate (pNp) as a substrate and measuring absorbance at 405nm. Assay protocol is based on Nakamura et al [42] with buffer modifications provided by the recombinant Wnt manufacturer (R&D Systems). A more detailed protocol is available upon request.
para-Nitrophenyl Phosphate tablets were obtained from Cayman Chemical (cat# 400090).
Proliferation and viability assays
Cell were seeded in a 96-well plate and 24hrs later cells were treated with 100nM Sytox green (Thermo Fisher Scientific, cat# S7020). The plate was then placed into an Incucyte Zoom for 4-5 days where they were imaged every 4hrs at 10x magnification. Cell confluence and cell death (Sytox green-positive counts) were assessed using Incucyte S3 software (v2018A). After time-course completion, total double- 
Gene expression analyses
RNA extractions were performed using the RNeasy Mini kit (Qiagen); mRNA was converted to cDNA on an Eppendorf Mastercycler Pro and using Promega reagents: Oligo (dT) 15 Chemiluminescence was used to detect antibodies and either film or the Licor c-Digit was used to develop the immunoblots. Of note, WNT4 MAB4751 detects a prominent non-specific band at ~50kD in immunoblots from cell lysates. This non-specific target largely precludes detection of WNT4, but cutting immunoblot membranes immediately below a 50kD ladder marker prevents this issue. This non-specific band was not detected in WNT4 immunoblots from conditioned medium. Similarly, in immunoblots of conditioned medium WNT3A MAB13242 detects a prominent non-specific band at ~60kD that precludes detection of secreted WNT3A; cutting membranes above a 50kD ladder marker prevents this issue. This non-specific band was not detected in WNT3A immunoblots from cell lysates.
Protein Transfection
HT1080 wild type cells were seeded into a 24-well plate at 100,000 cell/well. 24hrs later, protein transfection was performed using the Pierce Protein Transfection Reagent (ThemoFisher Cat# 89850).
The FITC antibody control was provided with the transfection reagent. All protein transfections were carried out per the manufacturer's instructions, with protein concentrations of 4ug/ml (1ug/24-well). Cells were harvested for whole cell lysate as above 4hr after transfection.
Results

PORCN inhibition does not mimic WNT4 siRNA in lobular carcinoma cells
We hypothesized that since ILC cells are dependent on WNT4 for proliferation and survival [38] , These data suggest PORCN inhibition is not sufficient to inhibit WNT4 function, and WNT4 signaling likely occurs via PORCN-independent mechanisms.
WNT4 secretion is PORCN-independent but WLS-dependent
Further investigation into mechanisms of WNT4 secretion utilized the HT1080 fibrosarcoma cell line, a well-characterized model for Wnt secretion, signaling, and activity; HT1080 have also been shown to increase DVL activation upon WNT4 over-expression [8] . The role of PORCN in WNT4 secretion was first assessed via transient over-expression of either WNT4 or WNT3A. HT1080 cells were reverse transfected with siPORCN, alone or in combination treatment with one of two PORCNi, WntC59 or
LGK974, followed by transfection with V5-tagged WNT4 or WNT3A [8] . Conditioned media (CM) was collected 24hr later, and secreted Wnts were detected by immunoblotting for the V5 tag. As expected, WNT3A secretion was wholly PORCN-dependent in the HT1080 cell line, as either siPORCN or PORCNi blocked secretion (Figure 2A) . In contrast, siPORCN and PORCNi alone or in conjunction could not completely suppress WNT4 secretion (Figure 2A Figure 2C) . The same results were obtained when HT1080:W3 cells were treated with LGK974 (Supplemental Figure 2) . In contrast, WNT4 secretion was detected from both HT1080:W4 and HT1080-PKO:W4. Endogenously expressed WNT4 was also detected in conditioned medium from HT1080 and HT1080-PKO cell lines ( Figure 2C ).
Of note, WNT4 secretion from HT1080 did not increase with WNT4 over-expression, despite the increased WNT4 protein present in cell lysate ( Figure 2B ), suggesting WNT4 secretion is an active process that is saturated in HT1080 cells. We observed that secreted WNT4 can be resolved by electrophoresis as a doublet. The larger species was PORCN-dependent and not detected in HT1080-PKO, whereas all endogenous WNT4 shifted to the larger species in HT1080:W3 (Figure 2C ), potentially due to positive feedback activation of Wnt secretory activity [43] . We observed loss of both species in conditioned media after WNT4 knockdown by siRNA, confirming both secreted species as WNT4 (Supplemental Figure 2) . These data indicate that while WNT4 is modified by PORCN, PORCN is not required for WNT4 secretion.
PORCN-mediated palmitoylation of Wnt proteins is commonly described as being required for WLS binding and transport to the cell surface for secretion (see Introduction). However, given reports that WLS may be sufficient for secretion of some Wnt proteins (see Discussion), we examined the requisite of WLS for WNT4 secretion. Knockdown of WLS by siRNA suppressed secretion of both WNT3A and WNT4 from HT1080 ( Figure 2D ), demonstrating that while secretion of WNT3A is dependent on both PORCN and WLS, WNT4 secretion is PORCN-independent but WLS-dependent.
To examine Wnt secretion in the context of ILC, WNT3A and WNT4 over-expression models in MM134 cells were also generated ( Figure 2F ). While these data strongly indicate WNT4 secretion is PORCN-independent, they also suggest that Wnt protein processing and signaling may be more broadly atypical in ILC. However, it is unclear if Wnt proteins secreted independent of PORCN are competent to activate paracrine Wnt signaling.
Secreted WNT4 does not activate Wnt signaling pathways
Palmitoylation of Wnt proteins is widely described as necessary for WNTs to activate downstream signaling pathways. Given our observation of PORCN-independent WNT4 secretion, we assessed if (Figure 3A-B) . As expected, Wnt signaling activity was not observed using conditioned medium from HT1080-PKO:W3, consistent with a lack of WNT3A secretion in PORCN-null cells ( Figure 2C ). Neither HT1080:W4 nor HT1080-PKO:W4 conditioned media, however, activated Wnt signaling in the receiver cells ( Figure 3A-B) despite our ability to detect secreted WNT4 from both contexts. Similarly, conditioned medium from MM134:W4 did not initiate Wnt signaling in receiver cells (Figure 3C-D) . Conditioned medium from MM134:W3 also failed to activate Wnt signaling in receiver cells, despite the presence of WNT3A in conditioned medium from these cells (Figure 2F ), indicating that Wnt secretion is not sufficient for paracrine signaling in this cell line.
Since secreted WNT4 in conditioned media was unable to initiate paracrine Wnt signaling, we tested recombinant Wnt proteins WNT3A and WNT4 (rWNT3A and rWNT4) with HT1080-PKO receiver cells.
HT1080-PKO cells were treated with 10-500ng/mL rWNT proteins. rWNT3A activated Wnt signaling by all measures, while rWNT4 failed to activate Wnt signaling at any concentration (Figure 3E-F) . These data suggest that our above observations regarding secreted WNT4 are due to HT1080 being nonresponsive to paracrine WNT4. We confirmed the functionality of rWNTs by measuring canonical Wnt signaling activity in 3T3-E1 murine osteoblast cells via induction of alkaline phosphatase (AP) activity (see Materials and Methods). As expected, increasing concentrations of either rWNT3A or rWNT4
increased AP activity ( Figure 4A ) and both rWNT3A and rWNT4 induced DVL and LRP6 phosphorylation in 3T3-E1 cells ( Figure 4B ). Since 3T3-E1 are responsive to paracrine WNT4, we used these cells to assay to conditioned medium from WNT3A and WNT4 over-expressing cells as above.
Conditioned medium from HT1080:W3, but not HT1080-PKO:W3, induced AP activity (Figure 4C ), consistent with a requirement of PORCN for paracrine WNT3A signaling. However, though rWNT4
induced AP activity in 3T3-E1, conditioned medium from neither HT1080:W4 nor HT1080-PKO:W4
induced AP activity ( Figure 4C) . Parallel results were obtained in MM134, as conditioned medium from MM134:W3 induced AP activity in 3T3-E, which could be blocked by PORCNi treatment, and no AP activity was induced with MM134:W4 conditioned medium ( Figure 4D ). The amount of secreted WNT3A and WNT4 was confirmed as being within range of rWNT concentrations that induce AP activity in this assay (Figure 4E-G) . Notably, commercially available rWNT3A and rWNT4 are produced lacking the N-terminal signal peptide, and both rWNT3A and rWNT4 migrated as a smaller peptide than the corresponding Wnt protein secreted from either HT1080 or MM134 (Figure 4E-F above. Despite loss of WNT4 secretion, siWLS had no effect on MM134 proliferation or viability (Supplemental Figure 3A- 
WNT4 and WNT3A activate cell-autonomous signaling
Our observations suggest WNT4 may activate signaling by a cell-autonomous, rather than paracrine or autocrine, mechanism. We examined Wnt signaling activity (DVL and LRP6 phosphorylation, AXIN2 expression) directly in HT1080 and HT1080-PKO over-expressing WNT3A or WNT4 (Figure 5A-B WntD is secreted at high levels in fly tissues and cell culture models, independent of both Porcupine Our observations indicate WNT4 and WNT3A likely signal via at least three distinct mechanisms: 1) as a secreted protein with PORCN modification; 2) as a secreted protein without PORCN modification; 3) by a cell autonomous mechanism independent of secretion. This may offer explanation for the myriad of context-dependent signaling pathways activated by WNT4, including activating canonical β-catenin activity [14, 34, 48] , repressing β-catenin-driven transcription [49, 50] , or activating non-canonical Wnt signaling pathways [21, 51] . For example, PORCN-driven palmitoylation may mediate the ability of WNT4 to act via canonical vs non-canonical Wnt signaling, and/or via cell autonomous mechanisms.
Additionally, the differences we observed between recombinant and secreted WNT4 indicate differential protein processing may guide Wnt proteins to activate distinct signaling pathways. The commercially available recombinant Wnt proteins used in our study lack the N-terminal signal peptide (residues 1-22 for WNT4), however, Wnt signal peptides may have important roles in regulation of signaling activity [52] . The WNT4 signal peptide has uniquely high percentages of arginine (14%) and serine (18%) compared to other human Wnts (average 5% and 9%, respectively), whereas WNT3A has no charged or polar residues in its signal peptide. Mutation in the signal peptide (L12P) of WNT4 has also been linked to Mayer-Rokitansky-Küster-Hauser syndrome [23] . The L12P mutant functions as a dominant negative inhibitor and suppresses the activity of wild-type WNT4 when co-expressed. Although the L12P mutant protein is not palmitoylated, it is secreted and does not prevent secretion of wild-type protein. These observations are consistent with our findings of PORCN-independent WNT4 secretion. The mechanism of dominant-negative activity has not been described but suggests distinct forms of WNT4 may drive cell autonomous Wnt signaling. Identifying the sequence and protein modifications of potential WNT4
species is an important future direction.
To our knowledge, this is the first report of PORCN-independent Wnt activity that is also independent of secretion. The studies discussed above showed Wnt proteins secreted in PORCN-independent manners were active in paracrine signaling models, although it was not reported whether Rab1-mediated secretion of WntD was ultimately required for signaling [44] . We observed that secreted WNT4 was unable to activate paracrine signaling in any model system tested, and that cell autonomous activation of DVL proteins could only be achieved by directly expressing or transfecting WNT3A or WNT4 protein in cells.
Cell autonomous DVL phosphorylation appeared to be independent of membrane receptor activation, as increased phospho-LRP6 was not seen in WNT4 [40] , which leads to dysfunction of catenin proteins, including activation of p120 catenin [53] , or in-activation of β-catenin. E-cadherin loss in ILC leads to a loss of β-catenin protein in both patient tumors and cell lines [38, 40] , and as a result β-catenin-driven TOP-Flash reporter activity cannot be activated in ILC cells [38] . This catenin protein dysfunction was previously postulated as being linked to PORCNi sensitivity, and ILC patients were specifically included in a trial of WNT974 (NCT01351103). This trial opened in 2011, but by 2015 ILC patients were removed from the inclusion criteria. It is unclear whether this is due to accrual problems or a lack of efficacy, as neither have been specifically reported for ILC patients on this trial, although our data suggest PORCNi are unlikely to have clinical efficacy for ILC. This highlights the importance of defining the unique context for Wnt signaling in ILC, in particular for WNT4, based on our prior findings [38] . Our laboratory has begun to characterize WNT4-driven signaling in ILC cells, which may be mediated by PORCN-independent, cell autonomous WNT4 signaling.
Strengths of our study include the use of diverse cell line models to investigate Wnt secretion and paracrine activity of Wnt proteins, which allowed us to identify the context-dependent Wnt signaling described herein. We used primarily non-tagged Wnt expression constructs, which eliminated previously described complications with altered processing and reduced activity for tagged Wnt proteins. Wnt signaling activity was measured by diverse yet redundant pathway readouts that facilitated our study of context-dependent Wnt signaling activities. Notably, the cell line models used for Wnt secretion were both cancer-derived, and thus it is unclear how our observations will translate to normal tissue, developmental, or in vivo contexts. We observed identical processing and secretion for endogenously expressed WNT4 as for over-expressed WNT4 (neither model expresses endogenous WNT3A), but overexpression was required to facilitate signaling experiments. As such, future studies will need to determine the contribution of endogenous Wnt protein levels to activating the signaling pathways discussed herein.
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